Open AccessSVZ-nested GBM-initiating cells are resistant to radiotherapy treatment, due to mesenchymal activation by SVZ-released CXCL12.
Author(s) -
Arnaud Lombard,
Nicolas Goffart,
Matthias Dedobbeleer,
Estelle Willems,
Martin Didier,
Bernard Rogister
Publication year - 2016
Publication title -
frontiers in aging neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.827
H-Index - 78
ISSN - 1663-4365
DOI - 10.3389/conf.fnagi.2016.03.00091
Subject(s) - mesenchymal stem cell , radiation therapy , chemistry , cancer research , medicine , neuroscience , psychology , pathology